lactic acid has been researched along with oritavancin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ardanuy, C; Cabellos, C; Fernà ndez, A; Gudiol, F; Liñares, J; Maiques, JM; Tubau, F; Viladrich, PF | 1 |
1 other study(ies) available for lactic acid and oritavancin
Article | Year |
---|---|
Experimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Ceftriaxone; Cephalosporin Resistance; Colony Count, Microbial; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Female; Glycopeptides; Lactic Acid; Leukocyte Count; Lipoglycopeptides; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Rabbits; Streptococcus pneumoniae | 2003 |